Cargando…
Management of COVID patients with convalescent plasma: Do we have the final word?
Immunotherapy with convalescent plasma (CP) has been used in the past in several different infectious diseases and proposed as a potential therapeutic option in patients with COVID-19. However, a clear benefit was never demonstrated and randomized clinical trials (RCTs) conducted in different popula...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630688/ https://www.ncbi.nlm.nih.gov/pubmed/34895816 http://dx.doi.org/10.1016/j.ejim.2021.10.029 |